Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study

Pharmacist-Driven Alcohol Use Disorder Screening May Increase Inpatient Utilization of Extended-Release Naltrexone: A Single Center Pilot Study

Individuals with mental illness have a high incidence of comorbid substance use, with one of the most prevalent being alcohol use disorder (AUD). Naltrexone, FDA-approved for AUD, decreases reward associated with alcohol-related social cues. This study aimed to determine if a pharmacist-driven scree...

Full description

Bibliographic Details
Main Authors: Sabrina Snyder, Niyati Butala, Andrew M. Williams, Jamie Kneebusch
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmacy
Subjects:
alcohol use disorder
inpatient
mental health
naltrexone
patient readmission
pharmacist
Online Access:https://www.mdpi.com/2226-4787/12/1/26

Internet

https://www.mdpi.com/2226-4787/12/1/26

Similar Items